Skip to main content
Erschienen in: Clinical Rheumatology 8/2016

18.09.2015 | Case Based Review

Pure lupus podocytopathy first presenting as thrombotic thrombocytopenic purpura-like syndrome

verfasst von: Guillermo Delgado-García, Carlos Cámara-Lemarroy, Adrián Infante-Valenzuela, Perla Colunga-Pedraza, Gabriela Alarcón-Galván, Arian Armenta-González, Héctor Jorge Villarreal-Velázquez

Erschienen in: Clinical Rheumatology | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

Lupus podocytopathy (LP) is an uncommon proteinuric disorder in the spectrum of lupus nephropathy. Its histological features are similar to those described in minimal change disease (MCD) with or without mesangial immune deposits. Although infrequent, a close relationship between systemic lupus erythematosus (SLE) and thrombotic thrombocytopenic purpura (TTP) is well accepted. Proteinuria in the setting of SLE has previously been associated with the development of TTP-like syndrome. As far as we know, LP first presenting as a TTP-like syndrome has never been reported. Here, we describe the case of a previously healthy 45-year-old woman who developed simultaneously these two conditions and then we briefly review the literature on the topic, emphasizing the previous cases of concurrent initial diagnosis of both SLE and MCD (n = 7) and SLE and TTP (n = 72). In conclusion, renal biopsy is central to the management of SLE patients with nephrotic syndrome. Furthermore, in a SLE patient with anemia and thrombocytopenia, TTP should be part of the differential diagnosis, even when no schistocytes were detected in peripheral blood smear.
Literatur
1.
Zurück zum Zitat Lewis EJ (2010) Lupus podocytopathy. In: Lupus Nephritis. Oxford University Press, Oxford, pp 199–210CrossRef Lewis EJ (2010) Lupus podocytopathy. In: Lupus Nephritis. Oxford University Press, Oxford, pp 199–210CrossRef
2.
Zurück zum Zitat Mok CC, Cheung TT, Lo WH (2010) Minimal mesangial lupus nephritis: a systematic review. Scand J Rheumatol 39(3):181–189CrossRefPubMed Mok CC, Cheung TT, Lo WH (2010) Minimal mesangial lupus nephritis: a systematic review. Scand J Rheumatol 39(3):181–189CrossRefPubMed
3.
Zurück zum Zitat Matsuyama T, Kuwana M, Matsumoto M, Isonishi A, Inokuma S, Fujimura Y (2009) Heterogeneous pathogenic processes of thrombotic microangiopathies in patients with connective tissue diseases. Thromb Haemost 102(2):371–378PubMed Matsuyama T, Kuwana M, Matsumoto M, Isonishi A, Inokuma S, Fujimura Y (2009) Heterogeneous pathogenic processes of thrombotic microangiopathies in patients with connective tissue diseases. Thromb Haemost 102(2):371–378PubMed
4.
Zurück zum Zitat Jiang H, An X, Li Y, Sun Y, Shen G, Tu Y, Tao J (2014) Clinical features and prognostic factors of thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus: a literature review of 105 cases from 1999 to 2011. Clin Rheumatol 33(3):419–427CrossRefPubMed Jiang H, An X, Li Y, Sun Y, Shen G, Tu Y, Tao J (2014) Clinical features and prognostic factors of thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus: a literature review of 105 cases from 1999 to 2011. Clin Rheumatol 33(3):419–427CrossRefPubMed
5.
Zurück zum Zitat Hunt BJ, Tueger S, Pattison J, Cavenagh J, D’Cruz DP (2007) Microangiopathic haemolytic anaemia secondary to lupus nephritis: an important differential diagnosis of thrombotic thrombocytopenic purpura. Lupus 16(5):358–362CrossRefPubMed Hunt BJ, Tueger S, Pattison J, Cavenagh J, D’Cruz DP (2007) Microangiopathic haemolytic anaemia secondary to lupus nephritis: an important differential diagnosis of thrombotic thrombocytopenic purpura. Lupus 16(5):358–362CrossRefPubMed
6.
Zurück zum Zitat Wang Y, Yu F, Song D, Wang SX, Zhao MH (2014) Podocyte involvement in lupus nephritis based on the 2003 ISN/RPS system: a large cohort study from a single centre. Rheumatology (Oxford) 53(7):1235–1244CrossRef Wang Y, Yu F, Song D, Wang SX, Zhao MH (2014) Podocyte involvement in lupus nephritis based on the 2003 ISN/RPS system: a large cohort study from a single centre. Rheumatology (Oxford) 53(7):1235–1244CrossRef
7.
Zurück zum Zitat Matsumura N, Dohi K, Shiiki H, Morita H, Yamada H, Fujimoto J et al (1989) Three cases presenting with systemic lupus erythematosus and minimal change nephrotic syndrome. Nihon Jinzo Gakkai Shi 31(9):991–999PubMed Matsumura N, Dohi K, Shiiki H, Morita H, Yamada H, Fujimoto J et al (1989) Three cases presenting with systemic lupus erythematosus and minimal change nephrotic syndrome. Nihon Jinzo Gakkai Shi 31(9):991–999PubMed
8.
Zurück zum Zitat Guery B, Martinez F, Beaufils H, Deray G (1997) Minimal-change nephropathy associated with systemic lupus erythematosus. Nephrol Dial Transplant 12(9):2030–2031CrossRefPubMed Guery B, Martinez F, Beaufils H, Deray G (1997) Minimal-change nephropathy associated with systemic lupus erythematosus. Nephrol Dial Transplant 12(9):2030–2031CrossRefPubMed
9.
Zurück zum Zitat Seo DB, Lee SW, Song JH, Lee KJ, Han JY, Kim MJ (2002) Acute renal failure associated with a minimal change nephrotic syndrome in a systemic lupus erythematosus patient. Yonsei Med J 43(1):114–118CrossRefPubMed Seo DB, Lee SW, Song JH, Lee KJ, Han JY, Kim MJ (2002) Acute renal failure associated with a minimal change nephrotic syndrome in a systemic lupus erythematosus patient. Yonsei Med J 43(1):114–118CrossRefPubMed
10.
Zurück zum Zitat Hertig A, Droz D, Lesavre P, Grünfeld JP, Rieu P (2002) SLE and idiopathic nephrotic syndrome: coincidence or not? Am J Kidney Dis 40(6):1179–1184CrossRefPubMed Hertig A, Droz D, Lesavre P, Grünfeld JP, Rieu P (2002) SLE and idiopathic nephrotic syndrome: coincidence or not? Am J Kidney Dis 40(6):1179–1184CrossRefPubMed
11.
Zurück zum Zitat Hsieh RY, Wu AB, Chang YT, Cheng MF, Wein-Chung Chen WC, Huang JJ (2007) Minimal change nephrotic syndrome in two patients with suspected systemic lupus erythematosus: association or co-incidence. Acta Nephrologica 21(1):52–57 Hsieh RY, Wu AB, Chang YT, Cheng MF, Wein-Chung Chen WC, Huang JJ (2007) Minimal change nephrotic syndrome in two patients with suspected systemic lupus erythematosus: association or co-incidence. Acta Nephrologica 21(1):52–57
12.
Zurück zum Zitat Moysés-Neto M, Costa RS, Rodrigues FF, Vieira Neto OM, Reis MA, Louzada Júnior P et al (2011) Minimal change disease: a variant of lupus nephritis. NDT Plus 4(1):20–22PubMed Moysés-Neto M, Costa RS, Rodrigues FF, Vieira Neto OM, Reis MA, Louzada Júnior P et al (2011) Minimal change disease: a variant of lupus nephritis. NDT Plus 4(1):20–22PubMed
13.
Zurück zum Zitat Shahane A, Khasnis A, Gota C (2012) Rituximab-responsive nephrotic syndrome due to minimal change disease in systemic lupus erythematosus. J Clin Rheumatol 18(4):199–202CrossRefPubMed Shahane A, Khasnis A, Gota C (2012) Rituximab-responsive nephrotic syndrome due to minimal change disease in systemic lupus erythematosus. J Clin Rheumatol 18(4):199–202CrossRefPubMed
14.
Zurück zum Zitat Hu WX, Chen YH, Bao H, Liu ZZ, Wang SF, Zhang HT, Liu ZH (2015) Glucocorticoid with or without additional immunosuppressant therapy for patients with lupus podocytopathy: a retrospective single-center study. Lupus 24:1067–75. doi:10.1177/0961203315578766 CrossRefPubMed Hu WX, Chen YH, Bao H, Liu ZZ, Wang SF, Zhang HT, Liu ZH (2015) Glucocorticoid with or without additional immunosuppressant therapy for patients with lupus podocytopathy: a retrospective single-center study. Lupus 24:1067–75. doi:10.​1177/​0961203315578766​ CrossRefPubMed
15.
Zurück zum Zitat Dube GK, Markowitz GS, Radhakrishnan J, Appel GB, D’Agati VD (2002) Minimal change disease in systemic lupus erythematosus. Clin Nephrol 57(2):120–126CrossRefPubMed Dube GK, Markowitz GS, Radhakrishnan J, Appel GB, D’Agati VD (2002) Minimal change disease in systemic lupus erythematosus. Clin Nephrol 57(2):120–126CrossRefPubMed
16.
Zurück zum Zitat Harirforoosh S, Jamali F (2009) Renal adverse effects of nonsteroidal anti-inflammatory drugs. Expert Opin Drug Saf 8(6):669–681CrossRefPubMed Harirforoosh S, Jamali F (2009) Renal adverse effects of nonsteroidal anti-inflammatory drugs. Expert Opin Drug Saf 8(6):669–681CrossRefPubMed
17.
Zurück zum Zitat Whelton A (1999) Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med 106(5B):13S–24SCrossRefPubMed Whelton A (1999) Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med 106(5B):13S–24SCrossRefPubMed
18.
Zurück zum Zitat Wang YT, Chou HH, Chen FF, Chen MJ, Chiou YY (2006) A case of minimal-change nephrotic syndrome in pediatric lupus erythematosus: just a coincidence? Lupus 15(4):244–247CrossRefPubMed Wang YT, Chou HH, Chen FF, Chen MJ, Chiou YY (2006) A case of minimal-change nephrotic syndrome in pediatric lupus erythematosus: just a coincidence? Lupus 15(4):244–247CrossRefPubMed
19.
Zurück zum Zitat Klonizakis P, Tselios K, Sarantopoulos A, Gougourellas I, Rouka E, Onufriadou Z et al (2013) ADAMTS-13 metalloprotease abnormalities in systemic lupus erythematosus: is there a correlation with disease status? Lupus 22(5):443–452CrossRefPubMed Klonizakis P, Tselios K, Sarantopoulos A, Gougourellas I, Rouka E, Onufriadou Z et al (2013) ADAMTS-13 metalloprotease abnormalities in systemic lupus erythematosus: is there a correlation with disease status? Lupus 22(5):443–452CrossRefPubMed
20.
Zurück zum Zitat Dold S, Singh R, Sarwar H, Menon Y, Candia L, Espinoza LR (2005) Frequency of microangiopathic hemolytic anemia in patients with systemic lupus erythematosus exacerbation: distinction from thrombotic thrombocytopenic purpura, prognosis, and outcome. Arthritis Rheum 53(6):982–985CrossRefPubMed Dold S, Singh R, Sarwar H, Menon Y, Candia L, Espinoza LR (2005) Frequency of microangiopathic hemolytic anemia in patients with systemic lupus erythematosus exacerbation: distinction from thrombotic thrombocytopenic purpura, prognosis, and outcome. Arthritis Rheum 53(6):982–985CrossRefPubMed
21.
Zurück zum Zitat Lansigan F, Isufi I, Tagoe CE (2011) Microangiopathic haemolytic anaemia resembling thrombotic thrombocytopenic purpura in systemic lupus erythematosus: the role of ADAMTS13. Rheumatology (Oxford) 50(5):824–829CrossRef Lansigan F, Isufi I, Tagoe CE (2011) Microangiopathic haemolytic anaemia resembling thrombotic thrombocytopenic purpura in systemic lupus erythematosus: the role of ADAMTS13. Rheumatology (Oxford) 50(5):824–829CrossRef
22.
Zurück zum Zitat Merayo-Chalico J, Demichelis-Gómez R, Rajme-López S, Aparicio-Vera L, Barrera-Vargas A, Alcocer-Varela J et al (2014) Risk factors and clinical profile of thrombotic thrombocytopenic purpura in systemic lupus erythematosus patients. Is this a distinctive clinical entity in the thrombotic microangiopathy spectrum?: a case control study. Thromb Res 134(5):1020–1027CrossRefPubMed Merayo-Chalico J, Demichelis-Gómez R, Rajme-López S, Aparicio-Vera L, Barrera-Vargas A, Alcocer-Varela J et al (2014) Risk factors and clinical profile of thrombotic thrombocytopenic purpura in systemic lupus erythematosus patients. Is this a distinctive clinical entity in the thrombotic microangiopathy spectrum?: a case control study. Thromb Res 134(5):1020–1027CrossRefPubMed
23.
Zurück zum Zitat Musio F, Bohen EM, Yuan CM, Welch PG (1998) Review of thrombotic thrombocytopenic purpura in the setting of systemic lupus erythematosus. Semin Arthritis Rheum 28(1):1–19CrossRefPubMed Musio F, Bohen EM, Yuan CM, Welch PG (1998) Review of thrombotic thrombocytopenic purpura in the setting of systemic lupus erythematosus. Semin Arthritis Rheum 28(1):1–19CrossRefPubMed
24.
Zurück zum Zitat El Khayat SS, Medkouri G, Etomba AM, Zamd M, Gharbi MB, Ramadani B (2012) Thrombotic thrombocytopenic purpura and systemic lupus erythematosus: a rare and life-threatening association. Arab J Nephrol Transplant 5(2):103–105PubMed El Khayat SS, Medkouri G, Etomba AM, Zamd M, Gharbi MB, Ramadani B (2012) Thrombotic thrombocytopenic purpura and systemic lupus erythematosus: a rare and life-threatening association. Arab J Nephrol Transplant 5(2):103–105PubMed
25.
Zurück zum Zitat George JN, Chen Q, Deford CC, Al-Nouri Z (2012) Ten patient stories illustrating the extraordinarily diverse clinical features of patients with thrombotic thrombocytopenic purpura and severe ADAMTS13 deficiency. J Clin Apher 27(6):302–311CrossRefPubMed George JN, Chen Q, Deford CC, Al-Nouri Z (2012) Ten patient stories illustrating the extraordinarily diverse clinical features of patients with thrombotic thrombocytopenic purpura and severe ADAMTS13 deficiency. J Clin Apher 27(6):302–311CrossRefPubMed
26.
Zurück zum Zitat Campos LM, Spadoni MS, Michelin CM, Jesus AA, Carneiro JD, da Silva CA (2013) Thrombotic thrombocytopenic purpura at presentation of juvenile systemic lupus erythematosus patients. Rev Bras Reumatol 53(1):120–126CrossRefPubMed Campos LM, Spadoni MS, Michelin CM, Jesus AA, Carneiro JD, da Silva CA (2013) Thrombotic thrombocytopenic purpura at presentation of juvenile systemic lupus erythematosus patients. Rev Bras Reumatol 53(1):120–126CrossRefPubMed
27.
Zurück zum Zitat Cui J, Zhu TN, Zhao YQ, Zhang FC (2013) The clinical analysis of 14 cases of systemic lupus erythematosus complicated by thrombotic thrombocytopenic purpura. Zhonghua Nei Ke Za Zhi 52(5):383–386PubMed Cui J, Zhu TN, Zhao YQ, Zhang FC (2013) The clinical analysis of 14 cases of systemic lupus erythematosus complicated by thrombotic thrombocytopenic purpura. Zhonghua Nei Ke Za Zhi 52(5):383–386PubMed
28.
Zurück zum Zitat Palaniappan P, Lionel AP, Agarwal I, Mathai S, Mathew L, Agarwal S et al (2014) Cryosupernatant and immunosuppression as effective alternative therapies for TTP in three pediatric SLE patients. Indian J Hematol Blood Transfus 30(Suppl 1):232–236CrossRefPubMedPubMedCentral Palaniappan P, Lionel AP, Agarwal I, Mathai S, Mathew L, Agarwal S et al (2014) Cryosupernatant and immunosuppression as effective alternative therapies for TTP in three pediatric SLE patients. Indian J Hematol Blood Transfus 30(Suppl 1):232–236CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Hassan ATA, Elbadry MIY, Tawfik MA (2014) A case report of thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus: overlapping features. Am J Med Case Rep 2(10):206–213 Hassan ATA, Elbadry MIY, Tawfik MA (2014) A case report of thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus: overlapping features. Am J Med Case Rep 2(10):206–213
30.
Zurück zum Zitat Changcharoen B, Bolger DT Jr (2015) Thrombotic thrombocytopenic purpura as an initial presentation of systemic lupus erythematosus with acquired ADAMTS 13 antibody. BMJ Case Rep 20:2015 Changcharoen B, Bolger DT Jr (2015) Thrombotic thrombocytopenic purpura as an initial presentation of systemic lupus erythematosus with acquired ADAMTS 13 antibody. BMJ Case Rep 20:2015
31.
Zurück zum Zitat Prasun Giri P, Sinha R, Pal P, Sarkar B (2015) Therapeutic plasma exchange in paediatric SLE: a case series from India. Lupus 24(8):889–891CrossRefPubMed Prasun Giri P, Sinha R, Pal P, Sarkar B (2015) Therapeutic plasma exchange in paediatric SLE: a case series from India. Lupus 24(8):889–891CrossRefPubMed
32.
Zurück zum Zitat Song D, Wu LH, Wang FM, Yang XW, Zhu D, Chen M et al (2013) The spectrum of renal thrombotic microangiopathy in lupus nephritis. Arthritis Res Ther 15(1):R12CrossRefPubMedPubMedCentral Song D, Wu LH, Wang FM, Yang XW, Zhu D, Chen M et al (2013) The spectrum of renal thrombotic microangiopathy in lupus nephritis. Arthritis Res Ther 15(1):R12CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Zini G, d’Onofrio G, Briggs C, Erber W, Jou JM, Lee SH et al (2012) ICSH recommendations for identification, diagnostic value, and quantitation of schistocytes. Int J Lab Hematol 34(2):107–116CrossRefPubMed Zini G, d’Onofrio G, Briggs C, Erber W, Jou JM, Lee SH et al (2012) ICSH recommendations for identification, diagnostic value, and quantitation of schistocytes. Int J Lab Hematol 34(2):107–116CrossRefPubMed
34.
Zurück zum Zitat Oregel KZ, Ramdial J, Glück S (2013) Nonsteroidal anti-inflammatory drug induced thrombotic thrombocytopenic purpura. Clin Med Insights Blood Disord 6:19–22PubMedPubMedCentral Oregel KZ, Ramdial J, Glück S (2013) Nonsteroidal anti-inflammatory drug induced thrombotic thrombocytopenic purpura. Clin Med Insights Blood Disord 6:19–22PubMedPubMedCentral
35.
Zurück zum Zitat Hay SN, Egan JA, Millward PA, Bandarenko N, Brecher ME (2006) Patterns of platelet response in idiopathic TTP/HUS: frequency of declining platelet counts with plasma exchange and the recognition and significance of a pseudo refractory state. Ther Apher Dial 10(3):237–241CrossRefPubMed Hay SN, Egan JA, Millward PA, Bandarenko N, Brecher ME (2006) Patterns of platelet response in idiopathic TTP/HUS: frequency of declining platelet counts with plasma exchange and the recognition and significance of a pseudo refractory state. Ther Apher Dial 10(3):237–241CrossRefPubMed
36.
Zurück zum Zitat Tovoli F, De Giorgio R, Fabbri A et al (2011) Thrombotic thrombocytopenic purpura mimicking an acute meningoencephalitis. Acta Clin Belg 66(1):55–56CrossRefPubMed Tovoli F, De Giorgio R, Fabbri A et al (2011) Thrombotic thrombocytopenic purpura mimicking an acute meningoencephalitis. Acta Clin Belg 66(1):55–56CrossRefPubMed
37.
Zurück zum Zitat Nafil H, Tazi I, Mahmal L (2012) Purpura thrombotique thrombocytopénique (PTT) simulant une méningo-encéphalite. Rev Neurol (Paris) 168(11):873–874CrossRef Nafil H, Tazi I, Mahmal L (2012) Purpura thrombotique thrombocytopénique (PTT) simulant une méningo-encéphalite. Rev Neurol (Paris) 168(11):873–874CrossRef
38.
Zurück zum Zitat Bortoluzzi A, Scirè CA, Bombardieri S, Caniatti L, Conti F, De Vita S et al (2015) Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus. Rheumatology (Oxford) 54(5):891–898CrossRef Bortoluzzi A, Scirè CA, Bombardieri S, Caniatti L, Conti F, De Vita S et al (2015) Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus. Rheumatology (Oxford) 54(5):891–898CrossRef
39.
Zurück zum Zitat Morís G, García-Moncó JC (2014) Drug-induced aseptic meningitis and other mimics. In: CNS infections. Springer, London, pp 249–271CrossRef Morís G, García-Moncó JC (2014) Drug-induced aseptic meningitis and other mimics. In: CNS infections. Springer, London, pp 249–271CrossRef
40.
Zurück zum Zitat Weksler BB, Lehany AM (1991) Naproxen-induced recurrent aseptic meningitis. DICP 25(11):1183–1184PubMed Weksler BB, Lehany AM (1991) Naproxen-induced recurrent aseptic meningitis. DICP 25(11):1183–1184PubMed
41.
Zurück zum Zitat Gao H, Li C, Mu R, Guo YQ, Liu T, Chen S et al (2011) Subclinical hypothyroidism and its association with lupus nephritis: a case control study in a large cohort of Chinese systemic lupus erythematosus patients. Lupus 20(10):1035–1041CrossRefPubMed Gao H, Li C, Mu R, Guo YQ, Liu T, Chen S et al (2011) Subclinical hypothyroidism and its association with lupus nephritis: a case control study in a large cohort of Chinese systemic lupus erythematosus patients. Lupus 20(10):1035–1041CrossRefPubMed
42.
Zurück zum Zitat Shen L, Lu G, Dong N, Ma Z, Ruan C (2013) Simvastatin increases ADAMTS13 expression in podocytes. Thromb Res 132(1):94–99CrossRefPubMed Shen L, Lu G, Dong N, Ma Z, Ruan C (2013) Simvastatin increases ADAMTS13 expression in podocytes. Thromb Res 132(1):94–99CrossRefPubMed
43.
Zurück zum Zitat Thomas MR, McDonald V, Machin SJ, Scully MA (2011) Thrombotic thrombocytopenic purpura associated with statin therapy. Blood Coagul Fibrinolysis 22(8):762–763CrossRefPubMed Thomas MR, McDonald V, Machin SJ, Scully MA (2011) Thrombotic thrombocytopenic purpura associated with statin therapy. Blood Coagul Fibrinolysis 22(8):762–763CrossRefPubMed
Metadaten
Titel
Pure lupus podocytopathy first presenting as thrombotic thrombocytopenic purpura-like syndrome
verfasst von
Guillermo Delgado-García
Carlos Cámara-Lemarroy
Adrián Infante-Valenzuela
Perla Colunga-Pedraza
Gabriela Alarcón-Galván
Arian Armenta-González
Héctor Jorge Villarreal-Velázquez
Publikationsdatum
18.09.2015
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 8/2016
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-015-3069-9

Weitere Artikel der Ausgabe 8/2016

Clinical Rheumatology 8/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.